Prism Medico & Pharmacy Ltd (512217) — Board Meeting | 19 September 2026 (2 announcements)

19 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

1Board Meeting🟡 Notable Neutral📄 PDF

📢 Key Event

AGM approved FY2025-26 financials and director reappointments

🔄 What Changed

Reappointment of Davender Singh as director

💡 Investor Takeaway

Shareholders endorsed key governance and financial decisions, maintaining continuity in leadership and audit oversight.

The 24th Annual General Meeting of Prism Medico & Pharmacy Ltd was held on 19 September 2026 via video conference, where shareholders approved the audited standalone financial statements for FY2025-26, reappointed Davender Singh as director, retained Garg Mendiratta & Associates as auditors, appointed SDK & Associates as secretarial auditors for 2026-31, and sanctioned a strategic investment in Infuze Well Private Limited. The meeting concluded at 12:42 P.M. after transacting ordinary and special business items.

2Board Meeting🟡 Notable Neutral📄 PDF

📢 Key Event

24th AGM held on 19 September 2026 via video conference

🔄 What Changed

Reappointment of Davender Singh as director; appointment of new directors and auditors; approval of preferential issue variation and investment in Infuze Well Private Limited

🔮 What's Next

None

💡 Investor Takeaway

Shareholders approved key governance and investment decisions, including director appointments and related party investments.

Prism Medico & Pharmacy held its 24th Annual General Meeting on 19 September 2026 via video conference, where shareholders approved all resolutions including reappointing Davender Singh, appointing new directors and auditors, sanctioning preferential issue variations, and authorising related party investments in Infuze Well Private Limited. The meeting concluded at 12:42 PM after remote e-voting concluded on 18 September 2026.

📊 Stock Analysis — 512217 ✨ Ask AI About This

About Prism Medico & Pharmacy Ltd (512217)

Services · Trading · Listed on BSE

Market Cap: ₹39.32 CrROE: -5.0%ROCE: -2.8%

View full 512217 stock details →

📡 Get AI alerts when 512217 files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track 512217 — Free

💡 Ask AI about this filing

"What is the valuation of Infuze Well Private Limited's strategic investment?""How will the new director impact company strategy?""What is the expected return on the approved preferential issue variation?"

Ask AI Free →

📊 More 512217 filings

Announcement — 30 September 2026Prism Medico & Pharmacy Ltd announced that its insider trading window will close on October 1, 2026,...
🔴 Corporate Action — 30 September 2026Prism Medico & Pharmacy Limited informed BSE and MSED that it will not issue any non-convertible sec...
🟡 Voting Results — 22 September 2026At the 24th AGM held on 19 September 2026 via video conferencing, shareholders approved all 8 resolu...

See all 512217 filings →

🔥 Also filed on 19 September 2026

CANBKCanara BankCorporate Action NTPCGREENNTPC Green Energy LtdAnnouncement ABCOTSAB Cotspin India LtdAnnual Report MPSLTDMPS LtdCorporate Action SEAMECLTDSEAMEC LtdAnnouncement INDOFARMIndo Farm Equipment LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts for your stocks — summarized by AI daily

Set up your AI Radar — pick stocks, get daily email summaries of new filings.

Set up AI Radar — Free

Free account · 2 AI queries/day

Tools